English
Japanese
COVID Hot topics
-
Tocilizumab receives WHO prequalification
11 February, 2022
First monoclonal antibody treatment to receive prequalification…COVID-19
-
Novavax authorised
South Korea // 11 February, 2022
First doses on order…COVID-19
-
ECDC urges caution with antibody tests
10 February, 2022
New technical report for clinicians published…COVID-19
-
Nasal spray launched to treat COVID-19
India // 09 February, 2022
Glenmark in partnership with SaNOtize launched (PDF) a nasal spray to treat adult COVID-19...COVID-19
-
Omicron may last longer on surfaces than other variants
08 February, 2022
Variants of concerns assessed for survival on skin and plastic.COVID-19
-
Long-term cardiovascular outcomes of COVID-19
United States // 07 February, 2022
Increased risk not limited to individuals who required hospital treatment...COVID-19
-
Moderna gains full regulatory approval
United States // 05 February, 2022
Second vaccine to do so…COVID-19
-
Interim authorisation granted for Paxlovid
Singapore // 03 February, 2022
First oral treatment of COVID-19 approved for use in Singapore...COVID-19
-
Vaccine Update - Booster dose approved for some people
Libya // 03 February, 2022
Booster shot approved for people above 50...COVID-19
-
Study highlights challenges with interpreting at-home COVID-19 test results
United States // 03 February, 2022
Adults may struggle to interpret and act upon at home COVID-19 test...COVID-19
-
Community transmission of COVID-19
Tonga // 02 February, 2022
The first cases of COVID-19 acquired within Tonga....COVID-19
-
CDC updates guidance on the use of respirators
01 February, 2022
People can choose to use N95s now that shortages are not a concern.....COVID-19
-
Pfizer/BioNTech seeks FDA approval for paediatric dose
United States // 01 February, 2022
Advisory committee to meet 15 February…COVID-19
-
Novavax seeks FDA approval
United States // 31 January, 2022
Fourth vaccine for the US if approved…COVID-19
-
Moderna gets FDA approval
United States // 31 January, 2022
Second COVID-19 vaccine to receive full authorisation in adults…COVID-19
-
Vaccine update - Pfizer/BioNTech vaccine open to 12 to 17 year olds
Malawi // 31 January, 2022
COVID-19 vaccination expanded to 12 years and olderCOVID-19
-
Vaccine Update – Pfizer/BioNTech approved for children aged 5 to 11 years
Qatar // 31 January, 2022
Health authorities have approved Pfizer/BioNTech to be used in children aged 5 to 11 years...COVID-19
-
COVID-19 from pet hamster and onward transmission
Hong Kong (China SAR) // 30 January, 2022
COVID-19 transmission from hamsters to humans and onward spreadCOVID-19
-
Hypotheses of Omicron origin
30 January, 2022
Theories on origin of OmicronCOVID-19
-
ECDC updates guidance on ending isolation for people with COVID-19
29 January, 2022
Focus on Omicron transmission and shortening isolation....COVID-19
